Zhenni Liu

Dr. Zhenni Liu

National Center for Clinical Laboratories, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing Hospital/National Center of Gerontology, P.R. China., Beijing, China
+1
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 October 2022 in Journal of Clinical Laboratory Analysis
Verified
Journal Article
Open access
ZLZhenni Liu
Zhenni Liu
LJLizi Jin
Lizi Jin
WZWeiyan Zhou
Weiyan Zhou
CZChuanbao Zhang
Chuanbao Zhang
Background: Plasma renin activity (PRA) is one of the recommended screening indicators for primary aldosteronism (PA) diagnosis and had become increasingly important in hypertension identification, medication guidance, and endocrine disorder confirmation.Methods: To provide an overview of the PRA measurement progress and clinical value, this review summarizes the main contributing factors related to PRA measurement and necessary precautions during the entire analysis process. We also outline the characteristics of PRA in different endocrine diseases and their clinical utility.Results: Significant inconsistency was observed in PRA measurement methods, including immunoassay and isotope dilution liquid chromatography–tandem mass spectrometry (ID‐LC/MS/MS), which could be attributed to preanalytical, analytical, and postanalytical variations. Meanwhile, consensus about environmental and procedural factors during the entire analytical process, including storage temperature, incubation condition, blank subtraction, and standardized operational procedures across different self‐developed assay laboratories, could be important to minimize analytical variations. Furthermore, commutable uniform calibrators should be prepared to improve consistency, ultimately achieving accurate and reliable measurement of PRA.Conclusion: This review summarizes the clinical utilization of PRA as a biomarker in multiple diseases, elaborating on routine detection methods and the key factors in the analytical process. We also provide feasible strategies for improving standardization and facilitating PRA assessment for larger‐scale clinical applications.

4 September 2023 in Clinica Chimica Acta
Verified
Journal Article
Closed access
ZLZhenni Liu
Zhenni Liu
LJLizi Jin
Lizi Jin
ZMZijia Ma
Zijia Ma
XNXiaerbanu Nizhamuding
Xiaerbanu Nizhamuding
JZJie Zeng
Jie Zeng
CZChuanbao Zhang
Chuanbao Zhang

1 September 2022 in Annals of Laboratory Medicine
Verified
Journal Article
Open access
PDF file
YDYuhang Deng
Yuhang Deng
QLQingxiang Liu
Qingxiang Liu
ZLZhenni Liu
Zhenni Liu
HZHaijian Zhao
Haijian Zhao
WZWeiyan Zhou
Weiyan Zhou
CZChuanbao Zhang
Chuanbao Zhang
Yuhang Deng, M.D., Qingxiang Liu, M.S., Zhenni Liu, M.D., Haijian Zhao, M.D., Weiyan Zhou, M.D., and Chuanbao Zhang, M.D.. Ann Lab Med 2022;42:575-84. https://doi.org/10.3343/alm.2022.42.5.575

20 March 2024 in Clinica Chimica Acta
Verified
Journal Article
Closed access
ZLZhenni Liu
Zhenni Liu
ZMZijia Ma
Zijia Ma
LJLizi Jin
Lizi Jin
XNXiaerbanu Nizhamuding
Xiaerbanu Nizhamuding
JZJie Zeng
Jie Zeng
CZChuanbao Zhang
Chuanbao Zhang

6 January 2023 in Analytical Methods
Verified
Journal Article
Open access
PDF file
ZLZhenni Liu
Zhenni Liu
LJLizi Jin
Lizi Jin
JZJiangtao Zhang
Jiangtao Zhang
TZTianjiao Zhang
Tianjiao Zhang
JZJie Zeng
Jie Zeng
CZChuanbao Zhang
Chuanbao Zhang
This study explored the optimized plasma incubation strategies and a traceable, robust, and reproducible designed comparison method based on LC-MS/MS for quantifying plasma renin activity, which is expected to harmonize laboratory measurement.